Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000699208 | SCV000827908 | pathogenic | Multiple congenital exostosis | 2018-03-01 | criteria provided, single submitter | clinical testing | This variant has been reported in individuals affected with hereditary multiple osteochondromatosis (PMID: 9521425, Invitae). For these reasons, this variant has been classified as Pathogenic. A different missense substitution at this codon (p.Arg280Gly) has been determined to be pathogenic (PMID: 9463333). This suggests that the arginine residue is critical for EXT1 protein function and that other missense substitutions at this position may also be pathogenic. Experimental studies have shown that this missense changes leads to a loss of heparan sulfate biosynthesis (PMID: 11391482). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with serine at codon 280 of the EXT1 protein (p.Arg280Ser). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and serine. |
Gene |
RCV003126909 | SCV003803403 | likely pathogenic | not provided | 2022-08-09 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging loss-of-function impact (Cheung et al., 2001); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 9521425, 11391482) |